Roundtable: Increasing the Robustness of IVPT Experiments
In a recent Analytical Special Feature with Drug Development & Delivery, industry experts weigh in about the the impacts of AI and automation in analytical labs.
MedPharm CSO, Dr. Jon Lenn, discusses our unique automated diffusion cell system, MedFlux-HT®, and transepidermal water loss (TEWL) instrument used for IVPT studies.
Learn more about the advantages of these systems in the lab, and read the full feature here.
![MedPharm CSO, Dr. Jon Lenn](https://www.medpharm.com/wp-content/uploads/2024/03/Web-MedPharm-18741-Edit-700x1050.jpg)